financetom
Business
financetom
/
Business
/
Tesla's sales rout in some European markets continues for eighth month
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla's sales rout in some European markets continues for eighth month
Sep 1, 2025 3:43 AM

LONDON (Reuters) -Tesla's sales rout in some European markets extended to an eighth month in August amid mounting competition from both Chinese EV rivals and traditional automakers, as well as a backlash against CEO Elon Musk's courting of far-right parties.

Car registration numbers from France, Denmark and Sweden - the first European countries to report monthly numbers for August - also showed that Tesla's revamped Model Y has had little impact on stemming declining sales.

Data from France on Monday showed that registrations of new Tesla cars fell 47.3% in August versus the same month in 2024, while the overall car market grew nearly 2.2%.

Tesla registrations fell more than 84% in Sweden - where electric vehicle sales were flat and the market overall was up 6% - and dropped 42% in Denmark.

Norway, where Tesla has deep roots and virtually all new car sales are electric, remained an outlier with a 21.3% jump in registrations for the U.S. EV maker. But Chinese rival BYD saw registrations spike 218%.

Tesla's biggest European markets are Germany and the UK, which have also seen sales slump this year but have yet to report August sales.

Tesla has several problems in Europe.

The company has a small ageing lineup and has not released a new mass-market model since the Model Y in 2020, while new Chinese rivals and traditional automakers alike are flooding the market with fresh models.

"One reason we are continuing to see disappointing Tesla volumes can partially be attributed to a more competitive market environment," said Matthias Schmidt, European autos market analyst at Schmidt Automotive.

Schmidt added that Musk's insistence during the automaker's second-quarter investor call in July that "there are no issues with Tesla volumes on the European market", when its market share in western Europe fell to 1.7% in the first half of the year from 2.5% in 2024, made him "sound delusional."

Earlier this year Tesla representatives in Europe had argued that the automaker's sales decline was largely because production was shifting over to the revamped Model Y, which was Europe's top-selling car in 2023.

Deliveries of the revised Model Y began across much of Europe in June, but Model Y sales were down 46.5% in Denmark in August and 87% in Sweden.

Tesla's competitive problems have been compounded by Musk's politics - he helped bankroll Donald Trump's U.S. presidential election win last year and has championed European far-right parties - which have sparked a fierce consumer backlash.

Ginny Buckley, CEO of Electrifying.com, said the EV advice website has been tracking consumer sentiment towards Tesla since the beginning of the year.

"What's clear is that Musk's influence on the brand has become increasingly polarizing," Buckley said.

Over half of those surveyed by Electrifying.com said Elon Musk is putting them off buying a Tesla, "signalling Tesla's dominance is no longer a given."

Andy Leyland, co-founder of supply chain specialist SC Insights, said aside from increased competition and "stagnant product lines", Tesla faces "decreased brand loyalty and a loss of technological advantage."

He added that Tesla's sales are also being undermined by the low cost of used Tesla EVs in the secondhand market.

Tesla slashed the price of new cars dramatically starting in 2023, seriously undermining the value of used Teslas that are now being snapped up.

Marketcheck, which collects used vehicle data in the United Kingdom, said that sales of used Teslas hit a record in July, jumping 270%. The average price for a used Model Y hit a new low in July, down 41% since July 2023, Marketcheck said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved